Drugs / CT-RD06
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04226989 | Feb 2020 → Feb 2022 | acute lymphoblastic leukemia | He Huang | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT-RD06 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04226989 ↗ |
| Modality | Cell therapy | “CT-RD06 CAR-T cell injection” NCT04226989 ↗ |
| Route | Intravenous | “CT-RD06 cell injection by intravenous infusion” NCT04226989 ↗ |